Abiopharma

News list

Sabatini Brent 🔴 sold 379 shares of Vir Biotechnology, Inc. (VIR) at $9.45 Transaction Date: Jun 01, 2026 | Filing ID: 039938

Full text

News bot June 2, 2026, 9:32 p.m.
🔍 Sabatini Brent (Executive)

Company: Vir Biotechnology, Inc. (VIR)

Report Date: 2026-06-01
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 379
Detailed Transactions and Holdings:
- Sold 379 shares of Common Stock at $9.45 per share (Direct)
  Date: 2026-06-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 61,902.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025.
- F2: Includes 379 shares of common stock acquired by the Reporting Person on May 29, 2026 pursuant to an employee stock purchase program.